NASDAQ:IRTC iRhythm Technologies (IRTC) Stock Price, News & Analysis $107.11 -2.06 (-1.89%) As of 01:52 PM Eastern This is a fair market value price provided by Massive. Learn more. Add Compare Share Share Stock Analysis Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrendsBuy This Stock About iRhythm Technologies Stock (NASDAQ:IRTC) View Price History Chart DataSkip Price History Chart 1 Day 5 Days 30 Days 90 Days 1 Year Advanced 1 Day 1 Day 5 Days 30 Days 90 Days 1 Year Advanced Show volume Show extended hours Get iRhythm Technologies alerts:Sign Up Key Stats Today's Range$109.02▼$114.3550-Day Range$109.17▼$129.1652-Week Range$108.81▼$212.00Volume430,659 shsAverage Volume509,827 shsMarket Capitalization$3.52 billionP/E RatioN/ADividend YieldN/APrice Target$189.69Consensus RatingModerate Buy Company Overview iRhythm Technologies, Inc. is a medical technology company that develops and commercializes wearable cardiac monitoring devices and associated data analytics services. Founded in 2006 and headquartered in San Francisco, California, the company’s flagship product is the Zio® patch, a discreet, single-use, continuous ECG recorder designed to monitor heart rhythms for up to 14 days. iRhythm’s digital diagnostics platform combines biosensor technology with proprietary algorithms to detect arrhythmias and streamline data interpretation for physicians. The Zio service is prescribed by cardiologists and other healthcare providers to aid in the diagnosis of atrial fibrillation, bradycardia, tachycardia and other rhythm disorders. After wearing the water-resistant patch, patients mail it back to iRhythm’s central lab, where recorded data are analyzed using the company’s AI-powered architecture. A comprehensive report, including annotated ECG strips and rhythm diagnosis, is delivered directly to the prescribing clinician, helping to guide treatment decisions. iRhythm primarily serves the United States market through partnerships with hospitals, clinics and diagnostic laboratories, and the company has been expanding its global footprint through strategic collaborations and regulatory approvals in select international markets. Leadership is headed by President and Chief Executive Officer Kevin King, who has overseen product innovation and process enhancements to support scalable growth. iRhythm continues to invest in research and development to extend its diagnostic platform into emerging areas of cardiovascular care and digital health.AI Generated. May Contain Errors. Read More iRhythm Technologies Stock Analysis - MarketRank™See Top-Rated MarketRank™ Stocks77th Percentile Overall ScoreIRTC MarketRank™: iRhythm Technologies scored higher than 77% of companies evaluated by MarketBeat, and ranked 162nd out of 868 stocks in the medical sector. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation. Analyst's Opinion4.5 / 5Analyst RatingModerate Buy Consensus RatingiRhythm Technologies has received a consensus rating of Moderate Buy. The company's average rating score is 2.94, and is based on 2 strong buy ratings, 12 buy ratings, 1 hold rating, and 1 sell rating.Upside PotentialiRhythm Technologies has a consensus price target of $189.69, representing about 79.0% upside from its current price of $106.00.Amount of Analyst CoverageiRhythm Technologies has been the subject of 10 research reports in the past 90 days, demonstrating strong analyst interest in this stock.Read more about iRhythm Technologies' stock forecast and price target. Earnings and Valuation1.9 / 5Proj. Earnings Growth907.69% Earnings GrowthEarnings for iRhythm Technologies are expected to grow by 907.69% in the coming year, from $0.13 to $1.31 per share.Price to Earnings Ratio vs. the MarketThe P/E ratio of iRhythm Technologies is -124.92, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.Price to Earnings Ratio vs. SectorThe P/E ratio of iRhythm Technologies is -124.92, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.Price to Book Value per Share RatioiRhythm Technologies has a P/B Ratio of 22.36. P/B Ratios above 3 indicate that a company could be overvalued with respect to its assets and liabilities.Read more about iRhythm Technologies' valuation and earnings. Short Interest1.0 / 5Short Interest LevelBearish Percentage of Shares Shorted9.53% of the float of iRhythm Technologies has been sold short.Short Interest Ratio / Days to CoveriRhythm Technologies has a short interest ratio ("days to cover") of 5.11.Change versus previous monthShort interest in iRhythm Technologies has recently increased by 8.68%, indicating that investor sentiment is decreasing significantly. Dividend0.0 / 5Dividend StrengthN/A Dividend YieldiRhythm Technologies does not currently pay a dividend.Dividend GrowthiRhythm Technologies does not have a long track record of dividend growth. News and Social Media3.0 / 5News Sentiment0.80 News SentimentiRhythm Technologies has a news sentiment score of 0.80. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This news sentiment score is similar to the average news sentiment of Medical companies.News Coverage This WeekMarketBeat has tracked 5 news articles for iRhythm Technologies this week, compared to 5 articles on an average week.Search Interest4 people have searched for IRTC on MarketBeat in the last 30 days. This is an increase of 100% compared to the previous 30 days.MarketBeat Follows2 people have added iRhythm Technologies to their MarketBeat watchlist in the last 30 days. Company Ownership1.5 / 5Insider TradingSelling Shares Insider Buying vs. Insider SellingIn the past three months, iRhythm Technologies insiders have sold 3,924.50% more of their company's stock than they have bought. Specifically, they have bought $56,892.00 in company stock and sold $2,289,620.00 in company stock.Percentage Held by Insiders0.98% of the stock of iRhythm Technologies is held by insiders.Percentage Held by InstitutionsiRhythm Technologies has minimal institutional ownership at this time.Read more about iRhythm Technologies' insider trading history. Receive IRTC Stock News and Ratings via Email Sign-up to receive the latest news and ratings for iRhythm Technologies and its competitors with MarketBeat's FREE daily newsletter. Submit View SMS TermsSMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. IRTC Stock News Headlines2 reasons to like IRTC and 1 to stay skepticalJune 1 at 10:43 PM | msn.comiRhythm Technologies Shareholders Approve Governance and Incentive PlanMay 28, 2026 | tipranks.comSecret behind near perfectly timed stock trades…?After 20 years of professional trading, Ross Givens says this is the single most lucrative market strategy he has ever found - following an elite circle of traders who have quietly posted wins of 163%, 234%, and 1,787%. Givens has built a system that lets anyone track these traders' moves with nothing more than an internet connection. He recently unveiled it in a new briefing available now.June 2 at 1:00 AM | Traders Agency (Ad)iRhythm Holdings to Participate in Upcoming Investor ConferencesMay 19, 2026 | globenewswire.comBank of America Securities Reaffirms Their Buy Rating on Irhythm Technologies (IRTC)May 15, 2026 | theglobeandmail.comiRhythm Holdings, Inc. (IRTC) Presents at Bank of America Global Healthcare Conference 2026 TranscriptMay 13, 2026 | seekingalpha.comInsider Buying: iRhythm Technologies (NASDAQ:IRTC) Director Buys 5,312 Shares of StockMay 13, 2026 | insidertrades.comiRhythm Holdings, Inc. 2026 Q1 - Results - Earnings Call PresentationMay 4, 2026 | seekingalpha.comSee More Headlines IRTC Stock Analysis - Frequently Asked Questions How have IRTC shares performed this year? iRhythm Technologies' stock was trading at $177.44 at the beginning of 2026. Since then, IRTC stock has decreased by 40.3% and is now trading at $106.0010. How were iRhythm Technologies' earnings last quarter? iRhythm Technologies (NASDAQ:IRTC) announced its quarterly earnings results on Thursday, April, 30th. The company reported ($0.35) earnings per share (EPS) for the quarter, beating the consensus estimate of ($0.56) by $0.21. iRhythm Technologies's revenue for the quarter was up 25.6% on a year-over-year basis. Read the conference call transcript. When did iRhythm Technologies IPO? iRhythm Technologies (IRTC) raised $88 million in an initial public offering on Thursday, October 20th 2016. The company issued 6,294,118 shares at a price of $13.00-$15.00 per share. J.P. Morgan and Morgan Stanley acted as the underwriters for the IPO and Canaccord Genuity and BTIG were co-managers. Who are iRhythm Technologies' major shareholders? Top institutional investors of iRhythm Technologies include Arrowstreet Capital Limited Partnership (1.77%), Stephens Investment Management Group LLC (1.71%), Allspring Global Investments Holdings LLC (1.42%) and Bank of America Corp DE (1.32%). Insiders that own company stock include Quentin S Blackford, Mark J Day, Patrick Michael Murphy, Chad Patterson, Minang Turakhia, Sumi Shrishrimal, Daniel G Wilson, Mervin Smith, Abhijit Y Talwalkar, Brice Bobzien, Marc Wade Rosenbaum and Marc W Rosenbaum. View institutional ownership trends. How do I buy shares of iRhythm Technologies? Shares of IRTC stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services. What other stocks do shareholders of iRhythm Technologies own? Based on aggregate information from My MarketBeat watchlists, some other companies that iRhythm Technologies investors own include NVIDIA (NVDA), Meta Platforms (META), Broadcom (AVGO), Adobe (ADBE), Advanced Micro Devices (AMD), Arista Networks (ANET) and ServiceNow (NOW). Company Calendar Last Earnings4/30/2026Today6/02/202646th Annual William Blair Growth Stock Conference6/02/2026Truist Securities MedTech Conference 20266/16/2026Next Earnings (Estimated)7/30/2026Fiscal Year End12/31/2026Get Stock Alerts Health Indicator TradeSmith's Health IndicatorA long-term volatility-based measure designed for securities held 12 months or longer.Green: Strong and healthy uptrend with normal pullbacks.Yellow: Significant pullback but still within expected volatility.Red: Dropped beyond expected volatility; considered unhealthy. Red Zone (2m+) 1-Year History Jun 25 Sep 25 Dec 25 Mar 26 Jun 26 IRTC's financial health is in the Red zone, according to TradeSmith. IRTC has been in this zone for over 2 months. Industry, Sector and Symbol Stock ExchangeNASDAQ SectorMedical Industry MEDICAL INFO SYS Sub-IndustryMedical Equipment Current SymbolNASDAQ:IRTC CIK1388658 Webwww.irhythmtech.com Phone(415) 632-5700FaxN/AEmployees2,400Year Founded2006Price Target and Rating Average Price Target for iRhythm Technologies$189.69 High Price Target$255.00 Low Price Target$147.00 Potential Upside/Downside+77.1%Consensus RatingModerate Buy Rating Score (0-4)2.94 Research Coverage16 Analysts Profitability EPS (Trailing Twelve Months)($0.86) Trailing P/E RatioN/A Forward P/E Ratio823.90 P/E GrowthN/ANet Income-$44.55 million Net Margins-3.53% Pretax Margin-3.43% Return on Equity-10.26% Return on Assets-1.39% Debt Debt-to-Equity Ratio4.03 Current Ratio5.17 Quick Ratio4.98 Sales & Book Value Annual Sales$787.85 million Price / Sales4.47 Cash FlowN/A Price / Cash FlowN/A Book Value$4.74 per share Price / Book22.60Miscellaneous Outstanding Shares32,862,000Free Float32,540,000Market Cap$3.52 billion OptionableOptionable Beta1.33 Social Links 10 Stocks Powering The Next AI Boom The AI boom is creating opportunities across semiconductors, cloud computing, enterprise software, infrastructure, cybersecurity, and automation. Inside this report, you’ll find 10 companies positioned to benefit as artificial intelligence moves from hype to real-world deployment and becomes a core growth driver for corporate America.Get This Free Report This page (NASDAQ:IRTC) was last updated on 6/2/2026 by MarketBeat.com Staff. From Our PartnersSecret behind near perfectly timed stock trades…?After 20 years of professional trading, Ross Givens says this is the single most lucrative market strategy he ...Traders Agency | SponsoredThe Rare Earth Shift Few Saw ComingRare earth elements sit inside modern defense systems, high-performance magnets, and advanced electronics - ye...i2i Marketing Group, LLC | SponsoredBNZI posted 169 percent revenue growth - is a turnaround formingBanzai International (NASDAQ: BNZI) reported full-year 2025 revenue of $12.2 million, up 169% year-over-year, ...Huge Alerts | SponsoredHow to claim a stake in SpaceX before the June 12 IPOSpaceX is expected to go public on June 12 - and for the first time, everyday investors may have a way in befo...Brownstone Research | SponsoredTrump's gold order: the announcement they won't put on the front pageOn August 15, 1971, Nixon interrupted prime-time television and ended the gold standard in 15 minutes - no deb...Reagan Gold Group | SponsoredGiving “2022 pre-ChatGPT” vibes (but 10x bigger)When ChatGPT launched in 2022, Nvidia surged 1,800% over three years. Now, Nvidia's CEO suggests July 22nd cou...StocksToTrade | SponsoredThe REAL Reason Trump is Invading IranFor a moment… Forget about Trump’s ties to Israel. Forget about reports of Iran’s nuclear program. Be...Banyan Hill Publishing | SponsoredIf You Have $50k+ on Coinbase, This Will Ruin Your DayOctober 14th, 2025, CNBC quietly published an interview with BlackRock's CEO, who went on live television and ...Decentralized Masters | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding iRhythm Technologies Please log in to your account or sign up in order to add this asset to your watchlist. Share iRhythm Technologies With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In Email Me a Login Link or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
